These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29411309)

  • 21. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C and kidney transplant: The eradication time of the virus has arrived.
    Esforzado N; Morales JM
    Nefrologia (Engl Ed); 2019; 39(5):458-472. PubMed ID: 30905391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.
    Ladino M; Roth D
    Nat Rev Nephrol; 2018 Jan; 14(1):6-8. PubMed ID: 29176656
    [No Abstract]   [Full Text] [Related]  

  • 24. Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
    Durand CM; Bowring MG; Brown DM; Chattergoon MA; Massaccesi G; Bair N; Wesson R; Reyad A; Naqvi FF; Ostrander D; Sugarman J; Segev DL; Sulkowski M; Desai NM
    Ann Intern Med; 2018 Apr; 168(8):533-540. PubMed ID: 29507971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study.
    Dharancy S; Coilly A; Fougerou-Leurent C; Duvoux C; Kamar N; Leroy V; Tran A; Houssel-Debry P; Canva V; Moreno C; Conti F; Dumortier J; Di Martino V; Radenne S; De Ledinghen V; D'Alteroche L; Silvain C; Besch C; Perré P; Botta-Fridlund D; Francoz C; Habersetzer F; Montialoux H; Abergel A; Debette-Gratien M; Rohel A; Rossignol E; Samuel D; Duclos-Vallée JC; Pageaux GP;
    Am J Transplant; 2017 Nov; 17(11):2869-2878. PubMed ID: 28898563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in China.
    Zhang J; Sun W; Lin J; Tian Y; Ma L; Zhang L; Zhu Y; Qiu W
    BMC Infect Dis; 2019 Jul; 19(1):645. PubMed ID: 31324230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA
    Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
    Naggie S; Muir AJ
    Annu Rev Med; 2017 Jan; 68():345-358. PubMed ID: 27686017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C and Treatment in Patients with Chronic Kidney Disease.
    Jalota A; Lindner BK; Thomas B; Lerma EV
    Dis Mon; 2021 Feb; 67(2):101017. PubMed ID: 32553421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct-acting agents for hepatitis C virus before and after liver transplantation.
    Sugawara Y; Hibi T
    Biosci Trends; 2018 Jan; 11(6):606-611. PubMed ID: 29238003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era.
    Devresse A; Delire B; Lazarus JV; Kabamba B; De Meyer M; Mourad M; Buemi A; Darius T; Cambier JF; Goffin E; Jadoul M; Kanaan N
    Transplant Proc; 2020 Apr; 52(3):815-822. PubMed ID: 32143864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective study.
    Gendia M; Lampertico P; Alfieri CM; D'Ambrosio R; Gandolfo MT; Campise MR; Fabrizi F; Messa P
    Transpl Int; 2019 May; 32(5):493-501. PubMed ID: 30580473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era.
    Radhakrishnan RC; Gopal B; Zachariah UG; Abraham P; Mohapatra A; Valson AT; Alexander S; Jacob S; Tulsidas KS; David VG; Varughese S
    Saudi J Kidney Dis Transpl; 2018; 29(5):1092-1099. PubMed ID: 30381505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL
    Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
    Kadatz M; Klarenbach S; Gill J; Gill JS
    Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Goldfarb DA
    J Urol; 2020 Dec; 204(6):1369. PubMed ID: 32955983
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up.
    Wettersten N; Tran H; Mekeel K; Pretorius V; Adler E; Aslam S
    Transpl Infect Dis; 2019 Feb; 21(1):e13002. PubMed ID: 30222242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.